Investor says troubled biotech company still has potential

    Insider
    Local businessman Martin Svendson, a shareholder in the much-hyped, early-stage biotech TransGenRx for about eight years, is part of a group that's trying "to bring the company back to life." The comp…

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.